The company has already completed 10,000 scans in its clinics in Stockholm and London and has a waiting list exceeding 100,000 people. Neko Health's non-invasive procedure uses over 70 sensors to collect 50 million data points, analyzed by AI to provide health insights. The recent funding will accelerate Neko's global expansion and investment in research and development. Co-founder Hjalmar Nilsonne emphasized the shift in healthcare towards proactive measures driven by technology and consumer demand, with plans to continue innovating to prevent diseases before they develop.
Key takeaways:
- Neko Health, co-founded by Spotify's Daniel Ek, secured $260 million in Series B funding to expand its AI-powered preventative healthcare services into the U.S.
- The funding round, led by Lightspeed Venture Partners, values Neko Health at approximately $1.8 billion and includes participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico.
- Neko Health offers a comprehensive full-body scanning service that uses over 70 sensors to collect 50 million data points, analyzed by AI to assess health risks such as skin cancer and cardiovascular issues.
- The company has completed 10,000 scans in Stockholm and London and has a waiting list of over 100,000 people, with plans for global expansion and further R&D investments.